Technical Analysis for EVFM - Evofem Biosciences, Inc.

Grade Last Price % Change Price Change
grade D 3.61 -1.37% -0.05
EVFM closed down 1.37 percent on Tuesday, March 19, 2019, on 7 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Up
See historical EVFM trend table...

Date Alert Name Type % Chg
Mar 19 20 DMA Support Bullish 0.00%
Mar 19 50 DMA Support Bullish 0.00%
Mar 19 180 Bullish Setup Bullish Swing Setup 0.00%
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 19 Narrow Range Bar Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 19 Gapped Down Weakness 0.00%
Mar 18 Shooting Star Candlestick Bearish -1.37%
Mar 18 Lizard Bearish Bearish Day Trade Setup -1.37%
Mar 18 MACD Bullish Centerline Cross Bullish -1.37%

Older signals for EVFM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Pharmaceutical Obesity
Is EVFM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 4 81 Biggest Movers From Friday
Mar 4 Edited Transcript of EVFM earnings conference call or presentation 1-Mar-19 4:00pm GMT
Mar 1 Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q4 2018 Results - Earnings Call Transcript
Mar 1 Evofem Biosciences +2% on Q4 results
Mar 1 Evofem Biosciences misses by $0.03
Mar 1 Evofem Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
Mar 1 Earnings Scheduled For March 1, 2019
Feb 22 The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
Feb 19 Evofem Biosciences to Report Fourth Quarter and Year-end 2018 Results and Provide Corporate Update on March 1, 2019
Jan 7 Evofem Biosciences, Amphora a Potential New Birth Control, Analysts Review and Target
See more EVFM news...
Indicators
Indicator Value
52 Week High 8.5
52 Week Low 1.79
Average Volume 24,221
200-Day Moving Average 3.3804
50-Day Moving Average 3.594
20-Day Moving Average 3.578
10-Day Moving Average 3.513
Average True Range 0.2195
ADX 18.47
+DI 24.5901
-DI 17.1428
Chandelier Exit (Long, 3 ATRs ) 3.4915
Chandelier Exit (Short, 3 ATRs ) 3.8585
Upper Bollinger Band 4.0729
Lower Bollinger Band 3.0831
Percent B (%b) 0.53
BandWidth 27.663499
MACD Line 0.0102
MACD Signal Line -0.0101
MACD Histogram 0.0203
Fundamentals Value
Market Cap 49.92 Million
Num Shares 13.8 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -4.88
Price-to-Sales 0.00
Price-to-Book 2.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.67
Resistance 3 (R3) 3.66 3.64 3.66
Resistance 2 (R2) 3.64 3.62 3.64 3.66
Resistance 1 (R1) 3.62 3.61 3.63 3.63 3.65
Pivot Point 3.60 3.60 3.60 3.60 3.60
Support 1 (S1) 3.58 3.58 3.59 3.59 3.57
Support 2 (S2) 3.56 3.57 3.56 3.56
Support 3 (S3) 3.54 3.56 3.56
Support 4 (S4) 3.55